论文部分内容阅读
目的探讨布地奈德雾化吸入辅助治疗肺炎患儿的临床疗效。方法选取2013年1月至2016年12月于河源市龙川县老隆镇卫生院住院治疗的317例肺炎患儿作为研究对象,按照随机数字表法分为A组(159例)与B组(158例)。A、B两组均给予患儿常规综合治疗,A组在常规综合治疗上再给予布地奈德雾化吸入治疗,比较两组患儿的治疗效果。结果 A组患儿治疗的总有效率明显高于B组,差异有统计学意义(P<0.05);A组患儿咳嗽、气喘、发热、肺部啰音等症状消失时间以及住院时间均明显短于B组,差异均有统计学意义(均P<0.05);A组患儿不良反应发生率明显低于B组,差异有统计学意义(P<0.05)。结论布地奈德雾化吸入对小儿肺炎有良好的疗效,且安全性高。
Objective To investigate the clinical efficacy of budesonide inhalation in the treatment of children with pneumonia. Methods From January 2013 to December 2016, 317 children with pneumonia hospitalized in Laolong Township Health Center, Longchuan County, Heyuan City were selected and divided into A group (159 cases) and B group according to random number table (158 cases). Groups A and B were given routine general treatment. Group A was treated with inhaled budesonide inhalation on routine combined treatment. The therapeutic effects of two groups were compared. Results The total effective rate of treatment in children in group A was significantly higher than that in group B (P <0.05). The disappearance time of cough, asthma, fever, pulmonary rales and other hospitalizations in group A were significantly longer than those in group B The difference was statistically significant (all P <0.05). The incidence of adverse reactions in group A was significantly lower than that in group B (P <0.05). Conclusion Budesonide inhalation has a good effect on pediatric pneumonia and is safe.